Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000898432-08-000171
Filing Date
2008-02-20
Accepted
2008-02-20 17:17:21
Documents
1
Group Members
BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.INVESTMENT 10, L.L.C.

Document Format Files

Seq Description Document Type Size
1 ariad-sc13g.txt SC 13G 24588
  Complete submission text file 0000898432-08-000171.txt   26903
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Subject) CIK: 0000884731 (see all company filings)

EIN.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-48751 | Film No.: 08630548
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611
Business Address 900 N. MICHIGAN AVENUE, SUITE 1100 CHICAGO IL 60611 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

EIN.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice